| HIV-exposed-uninfected infants have increased inflammation and monocyte activation S Dirajlal-Fargo, MM Mussi-Pinhata, A Weinberg, Q Yu, R Cohen, ... Aids 33 (5), 845-853, 2019 | 56 | 2019 |
| The effect of physical activity on cardiometabolic health and inflammation in treated HIV infection S Dirajlal-Fargo, AR Webel, CT Longenecker, B Kinley, D Labbato, ... Antiviral therapy 21 (3), 237-245, 2016 | 56 | 2016 |
| Changes in insulin resistance after initiation of raltegravir or protease inhibitors with tenofovir-emtricitabine: AIDS Clinical Trials Group A5260s S Dirajlal-Fargo, C Moser, TT Brown, T Kelesidis, MP Dube, JH Stein, ... Open forum infectious diseases 3 (3), ofw174, 2016 | 49 | 2016 |
| Vitamin K & D deficiencies are independently associated with COVID-19 disease severity AP Desai, S Dirajlal-Fargo, JC Durieux, H Tribout, D Labbato, ... Open Forum Infectious Diseases 8 (10), ofab408, 2021 | 39 | 2021 |
| Altered intestinal permeability and fungal translocation in Ugandan children with human immunodeficiency virus S Dirajlal-Fargo, V El-Kamari, L Weiner, L Shan, A Sattar, M Kulkarni, ... Clinical infectious diseases 70 (11), 2413-2422, 2020 | 36 | 2020 |
| Fungal translocation is associated with immune activation and systemic inflammation in treated HIV LD Weiner, M Retuerto, CL Hager, V El Kamari, L Shan, A Sattar, ... AIDS research and human retroviruses 35 (5), 461-472, 2019 | 30 | 2019 |
| HIV-positive youth who are perinatally infected have impaired endothelial function S Dirajlal-Fargo, A Sattar, M Kulkarni, E Bowman, N Funderburg, ... Aids 31 (14), 1917-1924, 2017 | 29 | 2017 |
| Insulin resistance and markers of inflammation in HIV-infected Ugandan children in the CHAPAS-3 trial S Dirajlal-Fargo, V Musiime, A Cook, G Mirembe, J Kenny, Y Jiang, ... The Pediatric infectious disease journal 36 (8), 761-767, 2017 | 28 | 2017 |
| Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial S Dirajlal-Fargo, B Kinley, Y Jiang, CT Longenecker, CO Hileman, ... Aids 29 (3), 313-321, 2015 | 21 | 2015 |
| Pediatric patients with SARS-CoV-2 infection: clinical characteristics in the United States from a large global health research network A Desai, A Mills, S Delozier, CC Aviles, A Edwards, S Dirajlal-Fargo, ... Cureus 12 (9), 2020 | 20 | 2020 |
| Changes in the fungal marker β-D-glucan after antiretroviral therapy and association with adiposity S Dirajlal-Fargo, C Moser, K Rodriguez, V El-Kamari, NT Funderburg, ... Open forum infectious diseases 6 (11), ofz434, 2019 | 20 | 2019 |
| Carbapenem-resistant Enterobacteriaceae in pediatric patients: epidemiology and risk factors S Dirajlal-Fargo, R DeBiasi, J Campos, X Song Infection Control & Hospital Epidemiology 35 (4), 447-449, 2014 | 20 | 2014 |
| Serum albumin is associated with higher inflammation and carotid atherosclerosis in treated human immunodeficiency virus infection S Dirajlal-Fargo, M Kulkarni, E Bowman, L Shan, A Sattar, N Funderburg, ... Open Forum Infectious Diseases 5 (11), ofy291, 2018 | 19 | 2018 |
| Brief report: zinc supplementation and inflammation in treated HIV S Dirajlal-Fargo, J Yu, M Kulkarni, A Sattar, N Funderburg, H Barkoukis, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 82 (3), 275-280, 2019 | 18 | 2019 |
| Increased monocyte and T-cell activation in treated HIV+ Ugandan children: associations with gut alteration and HIV factors S Dirajlal-Fargo, Z Albar, E Bowman, D Labbato, A Sattar, C Karungi, ... Aids 34 (7), 1009-1018, 2020 | 17 | 2020 |
| Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection S Dirajlal-Fargo, A Sattar, M Kulkarni, N Funderburg, GA McComsey HIV clinical trials 18 (4), 156-163, 2017 | 17 | 2017 |
| Subclinical vascular disease in children with human immunodeficiency virus in Uganda is associated with intestinal barrier dysfunction S Dirajlal-Fargo, Z Albar, E Bowman, D Labbato, A Sattar, C Karungi, ... Clinical infectious diseases 71 (12), 3025-3032, 2020 | 16 | 2020 |
| Plasma selenium concentrations are sufficient and associated with protease inhibitor use in treated HIV-infected adults CO Hileman, S Dirajlal-Fargo, SK Lam, J Kumar, C Lacher, GF Combs Jr, ... The Journal of nutrition 145 (10), 2293-2299, 2015 | 16 | 2015 |
| Insulin resistance and intestinal integrity in children with and without HIV infection in Uganda S Dirajlal‐Fargo, L Shan, A Sattar, E Bowman, J Gabriel, M Kulkarni, ... HIV medicine 21 (2), 119-127, 2020 | 15 | 2020 |
| HIV and cardiovascular disease: the role of inflammation S Dirajlal-Fargo, N Funderburg Current Opinion in HIV and AIDS 17 (5), 286-292, 2022 | 14 | 2022 |
Manjusha KulkarniEnvironmental Health and Safety SpecialistVerified email at kent.edu
